|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/20 | |
| A61K 9/50 | |||
| A61K 31/436 |
| (11) | Number of the document | 2763663 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12766990.1 |
| Date of filing the European patent application | 2012-10-03 | |
| (97) | Date of publication of the European application | 2014-08-13 |
| (45) | Date of publication and mention of the grant of the patent | 2017-12-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2012/069541 |
| Date | 2012-10-03 |
| (87) | Number | WO 2013/050419 |
| Date | 2013-04-11 |
| (30) | Number | Date | Country code |
| 201161544026 P | 2011-10-06 | US |
| (72) |
DIEDERICH, Anke, CH
LIECHTI, Kurt, CH
KUEHL, Peter, CH
CHEUNG, Wing, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | PHARMACEUTICAL COMPOSITIONS COMPRISING 40-O-(2-HYDROXY)ETHYL-RAPAMYCIN |
| PHARMACEUTICAL COMPOSITIONS COMPRISING 40-O-(2-HYDROXY)ETHYL-RAPAMYCIN |